SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-21-000894
Filing Date
2021-05-17
Accepted
2021-05-17 16:44:41
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q e2771_10-q.htm 10-Q 626068
2 EX-31 e2771_ex31-1.htm EX-31 8899
3 EX-31 e2771_ex31-2.htm EX-31 9025
4 EX-32 e2771_ex32-1.htm EX-32 5164
5 EX-32 e2771_ex32-2.htm EX-32 5242
  Complete submission text file 0001731122-21-000894.txt   3921302

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enob-20210331.xml EX-101.INS 600647
7 XBRL SCHEMA FILE enob-20210331.xsd EX-101.SCH 42669
8 XBRL CALCULATION FILE enob-20210331_cal.xml EX-101.CAL 57095
9 XBRL DEFINITION FILE enob-20210331_def.xml EX-101.DEF 197701
10 XBRL LABEL FILE enob-20210331_lab.xml EX-101.LAB 333656
11 XBRL PRESENTATION FILE enob-20210331_pre.xml EX-101.PRE 296632
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 21931629
SIC: 2834 Pharmaceutical Preparations